Adjuvant Nivolumab Provides Sustained DFS Benefit, Favors OS in Muscle-Invasive Urothelial Cancer
Simulations Improve CAR T-Cell Therapy Understanding and Administration Confidence
Orca-T May Be a Suitable Option Over PTCy-Based HSCT in Acute Leukemia and MDS
Orca-T Proves Safe and Effective in Advanced Hematologic Malignancies
2 Commerce Drive
Cranbury, NJ 08512